2Liu X,Zhong C,Zhao P,et al.Analysis of therapeutic effect and safety of target-dose metoprolol in the treatment of patients with diabetes mellitus with chronic heart failure[J].Pak J Med Sci,2014,30(1):7.
3Tendera M, Fox K, Ferrari R, et al.Clarify registry investi- gators. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry [ J ]. Int Cardiol, 2014, 176(1) :119-24.
4Jankovic SM. Pharmacokinetics of selective β-adrenergic blocking agents : prescribing implications [ J ]. Expert Opin Drug Metab Toxicol, 2014, 10(9) : 1221 - 1229.
5Azizi M, Perdrix L, Bobrie G, et al. Greater efficacy of al- dosterone blockade and diuretic reinforcement vs. dual renin -angiotensin blockade for left ventricular mass regression in patients with resistant hypertension [ J ].Hypertens, 2014, 32(10) :2038~2044.
6Dtingen HD, Musial-Bright L, Inkrot S, et al. Heart rate following short- term beta- blocker titration predicts all- cause mortality in elderly chronic heart failure patients: in- sights from the CIBIS-ELD trial[ J] .Eur Heart Fail, 2014, 16(8) :907~914.
